BNY MELLON STRATEGIC MUNICIPALS, INC.
No SEC Form 4 filings for $LEO in the last 30 days.
See all $LEO insider activity →LEO Pharma will pay $435M to acquire worldwide rights to Tanabe Pharma’s late-stage rare disease drug dersimelagon for EPP and XLP, photosensitivity disorders. LEO says Phase 3 INSPIRE data showed longer sun exposure vs placebo and fewer pain events. FDA submissions were made in June. LEO targets launch in 2027.
Lion Copper & Gold Corp. (CSE: LEO, OTCQB: LCGMF) said Douglas Stiles has stepped down from an executive management role and will remain a strategic advisor. Stiles will become President of Silver Bow Mining Corp. Lion stated the Yerington Copper Project permitting team remains engaged and the permitting program is on schedule.
LEO Technologies launched Verus Voice AI within its Verus AI platform, aimed at detecting PIN fraud and identity abuse in real time by analyzing inmate call audio and voice biometrics. The system generates alerts for investigators and facility staff with built-in safeguards requiring human review. Verus Voice AI is available to existing and new customers, according to the company.
Over the past 7 days, alphai's AI scored 1 news story mentioning LEO (BNY MELLON STRATEGIC MUNICIPALS, INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent LEO coverage spans financial news, mergers & acquisitions and technology.
The deal adds a late-stage dermatology asset with fast-track and orphan designations, potentially improving LEO’s future revenue optionality if FDA approval follows.
Management transition is unlikely to change near-term fundamentals, but it can affect execution confidence around the Yerington Copper Project permitting timeline.
The product launch can improve perceived competitiveness and adoption prospects for LEO’s Verus AI platform in corrections communications monitoring.
The announcement of a $0.026 monthly dividend with an annual yield of 5.1% is likely to attract income-focused investors, potentially supporting the stock price in the short term. The dividend increase or stability may also enhance investor confidence.
The distribution declaration by LEO suggests ongoing income generation, which may support investor confidence but is unlikely to cause significant short-term price movements.
alphai scores every news story that mentions LEO with an AI model for sentiment and relevance, and aggregates insider trades from BNY MELLON STRATEGIC MUNICIPALS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
LEO Pharma will pay $435M to acquire worldwide rights to Tanabe Pharma’s late-stage rare disease drug dersimelagon for EPP and XLP, photosensitivity disorders. LEO says Phase 3 INSPIRE data showed longer sun exposure vs placebo and fewer pain events. FDA submissions were made in June. LEO targets launch in 2027.
4 min readLion Copper & Gold Corp. (CSE: LEO, OTCQB: LCGMF) said Douglas Stiles has stepped down from an executive management role and will remain a strategic advisor. Stiles will become President of Silver Bow Mining Corp. Lion stated the Yerington Copper Project permitting team remains engaged and the permitting program is on schedule.
2 min readLEO Technologies launched Verus Voice AI within its Verus AI platform, aimed at detecting PIN fraud and identity abuse in real time by analyzing inmate call audio and voice biometrics. The system generates alerts for investigators and facility staff with built-in safeguards requiring human review. Verus Voice AI is available to existing and new customers, according to the company.
2 min readBNY Mellon Strategic Municipals, Inc. (NYSE:LEO) has declared a monthly dividend of $0.026 per share, payable on April 30th to shareholders of record by April 14th. This equates to an annualized yield of 5.1%. The company's shares opened at $6.09, with moving averages near $6.39 and $6.32, and a 52-week range of $5.55 to $6.55.
2 min readBNY Mellon Investment Adviser, Inc. announced that its Strategic Municipal Bond Fund, Inc. (DSM) and Strategic Municipals, Inc. (LEO) have declared monthly distributions of $0.026 per share. These distributions are payable on March 31, 2026, to shareholders of record as of March 12, 2026, with an ex-dividend date of March 12, 2026. BNY Investments, a division of BNY Mellon, manages these funds and is a major global asset manager.
2 min read
